Access brought to you by: LOCKSS

Viral Infections

Compliance Higher With Once-Daily Antibiotic Administration vs Multiple Times a Day
Dalbavancin Effective Treatment for Skin Infection Regardless of Weight Category
New Interferon-Free Treatment Strategies for HCV
Advances in Rapid Testing for Bacterial, Viral, and Parasitic Infections
Ebola Preparedness: A Panel Discussion
EDs Need to Recognize and Treat Highly Infectious Pathogens
DCV/ASV/BCV Improves Sustained Viral Response in Patients with Chronic HCV GT-1 Infection and Compensated Cirrhosis: UNITY-2 Results
SOF Plus GS-5816 Effective in Noncirrhotic Patients Infected with HCV GT-3: ELECTRON-2 Final Results
Myrcludex B Therapy Reduced HBV DNA and HDV RNA in Phase 2a Clinical Trial
SVR after Treatment of HCV Genotype 1a with ABT-450/Ritonavir, Ombitasvir, and Dasabuvir is Enhanced by RBV in Noncirrhotic Patients and by Extension of Duration in Cirrhotic Patients

Pages